Cargando…
Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort
BACKGROUND: To date, there has been no reliable in vitro test to either diagnose or differentiate nonsteroidal anti‐inflammatory drug (NSAID)–exacerbated respiratory disease (N‐ERD). The aim of the present study was to develop and validate an artificial neural network (ANN) for the prediction of N‐E...
Autores principales: | Tyrak, Katarzyna Ewa, Pajdzik, Kinga, Konduracka, Ewa, Ćmiel, Adam, Jakieła, Bogdan, Celejewska‐Wójcik, Natalia, Trąd, Gabriela, Kot, Adrianna, Urbańska, Anna, Zabiegło, Ewa, Kacorzyk, Radosław, Kupryś‐Lipińska, Izabela, Oleś, Krzysztof, Kuna, Piotr, Sanak, Marek, Mastalerz, Lucyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383769/ https://www.ncbi.nlm.nih.gov/pubmed/32012310 http://dx.doi.org/10.1111/all.14214 |
Ejemplares similares
-
Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021) -
Subphenotypes of nonsteroidal antiinflammatory disease‐exacerbated respiratory disease identified by latent class analysis
por: Celejewska‐Wójcik, Natalia, et al.
Publicado: (2020) -
Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease
por: Mastalerz, Lucyna, et al.
Publicado: (2023) -
Machine learning in the diagnosis of asthma phenotypes during coronavirus disease 2019 pandemic
por: Gawlewicz‐Mroczka, Agnieszka, et al.
Publicado: (2022) -
Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study
por: Mastalerz, L., et al.
Publicado: (2012)